An interventional study of LMA Protector in Airway Morbidity, sponsored by KK Women's and Children's Hospital. Completed at 1 site in Singapore. Open to female participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by KK Women's and Children's Hospital · Not applicable, Interventional, and Treatment
Evaluation of LMA Protector
This new disposable silicone airway device provides access and functional separation of the respiratory and digestive tracts. The airway tube is elliptical in cross section ending at the laryngeal opening. The device contains 2 drainage channels (male and female port) proximally that continues into a common distal opening posterior to the distal airway cuff bowl. The female port allows a gastric tube to be passed into the stomach, whilst a suction tube may be attached to the male suction port offering removal of gastric fluid around the upper oesophagus sphincter.
KK Women's and Children's Hospital is the lead sponsor of 136 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Single Use Supraglottic Airway Device with 2 ports for gastric access (male and female port)
Device: LMA Protector
Insertion of airway device for airway management during gynaecological procedure
Number of insertion attempts
Time of pickup of device to the presence of carbon dioxide trace on
Time frame: 5 minutes
Oropharyngeal Leak Pressure
Closure of expiratory valve of circle anaesthetic breathing system and noting the airway pressure in the breathing system at equilibration with cuff pressure of 60cmH2O or up to maximum of 40cmH2O
Time frame: 5 minutes
Plan to share: No
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
KK Women's and Children's Hospital